The [b]US Food and Drug Administration (FDA)[/b] has approved the first alternative to the long-used Pap test as a primary screening method for cervical cancer, in the face of opposition from some women’s groups and health organisations, reports [s]The New York Times[/s]. A coalition of 17 consumer, women’s and health groups opposed the approval, arguing that the new screening method, developed by Roche, had not been adequately tested and could upend a practice that has successfully prevented cervical cancer for decades. The FDA said, however, that the evidence was sufficient.
[link url=http://www.nytimes.com/2014/04/25/business/alternative-to-pap-test-is-approved-by-fda.html?emc=edit_th_20140425&nl=todaysheadlines&nlid=42505380&_r=0]Full report in The New York Times[/link]